Lakhasly

Cervical cancer remains the third most common cancer in women worldwide, with approximately 529,800 new cases and 275,100 deaths annually 1, 2.For example in China, a significantly increasing incidence and mortality trend are observed for cervical cancer, especially in young women 7.Cervical cancer incidence rates and deaths in well-developed countries have progressively declined 4 (Figure 2), due to cancer screening programs and HPV vaccination programs funded by huge government budgets 5.It is worth noting that in recent years, due to the lack of effective prevention/screening methods, incidences of cervical cancer are still increasing in developing countries

Cervical cancer remains the third most common cancer in women worldwide, with approximately 529,800 new cases and 275,100 deaths annually 1, 2. Of note, incidences of cervical cancer are disproportionally distributed between developed countries and less‐developed countries 3 (Figure 1). Cervical cancer incidence rates and deaths in well‐developed countries have progressively declined 4 (Figure 2), due to cancer screening programs and HPV vaccination programs funded by huge government budgets 5. In less‐developed countries 6, 7, however, cervical cancer is still one of the most prevalent cancers and the leading cause of cancer deaths in women, many of whom are often diagnosed at an age when they are still raising families. For example in China, a significantly increasing incidence and mortality trend are observed for cervical cancer, especially in young women 7. Cervical cancer has become the second most common female cancer and the third leading cause of cancer deaths in Chinese women aged 15 to 44 years 8. In India, cervical cancer ranks as the second leading cause of cancer in women. An estimated one‐fourth of the world's cervical cancer deaths every year (~77,100) occur in the second most populated country in the world 8, 9. It is worth noting that in recent years, due to the lack of effective prevention/screening methods, incidences of cervical cancer are still increasing in developing countries